1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,198 | 0,208 | 12:13 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | ARRAIL GROUP (06639): FURTHER DELAY IN PUBLICATION OF OUTSTANDING FINANCIAL RESULTS AND POSTPONEMENT OF ANNUAL GENERAL MEETING AND CONTINUED SUSPENSION ... | - | HKEx | ||
| 21.09. | ARRAIL GROUP (06639): REMUNERATION COMMITTEE - TERMS OF REFERENCE | - | HKEx | ||
| 01.09. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 30.06. | ARRAIL GROUP (06639): INSIDE INFORMATION - (1) DELAY IN PUBLICATION OF THE ANNUAL RESULTS FOR THE YEAR ENDED MARCH 31, 2026 AND FURTHER DELAY IN PUBLICATION ... | - | HKEx | ||
| ARRAIL GROUP Aktie jetzt für 0€ handeln | |||||
| 01.06. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 02.12.25 | XFRA I1D: AUSSETZUNG/SUSPENSION | 336 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTIL
ARRAIL... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 77,82 | -0,54 % | Zwei Dividendenwerte im Crash-Rabatt: Warum Cisco und Medtronic jetzt ins Visier konservativer Anleger rücken | Der jüngste Kursrückgang an den Aktienmärkten eröffnet nach Einschätzung eines Beitrags auf Seeking Alpha selektive Einstiegsgelegenheiten bei dividendenstarken Blue Chips. Im Fokus stehen Cisco Systems... ► Artikel lesen | |
| HCA HEALTHCARE | 395,30 | -0,40 % | Cantor Fitzgerald reiterates HCA Healthcare stock rating on stable labor | ||
| LANTHEUS | 89,50 | +0,22 % | Lantheus Holdings, Inc. - 8-K, Current Report | ||
| CAREDX | 56,00 | +0,90 % | Biotech Stocks At 52-Week Highs - CareDx +13%, Grail Inc. +15%, Twist Bioscience +16%, Adaptive Biotechnologies, Revvity | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 24, 2026, driven by key catalysts such as reaching certain regulatory milestones or results from clinical... ► Artikel lesen | |
| ENVISTA | 20,200 | 0,00 % | Envista Holdings Corporation: Envista Reports Second Quarter 2026 Results | BREA, Calif., Aug. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026.
"We built on our... ► Artikel lesen | |
| GT BIOPHARMA | 6,045 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma | FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocol Initiation of Phase 1 trial in MM patients contingent upon timing and receipt... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results | Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million
HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research... ► Artikel lesen | |
| CARMAT | - | - | CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy | The study's primary endpoint was achieved in 72.7% of the 55 patients implanted between December 2022 and May 2025.
This rate was significantly above the historical benchmark of 38% established... ► Artikel lesen | |
| CHEMOMETEC | 77,95 | +4,63 % | Chemometec A/S: Upgrade of revenue and operating profit guidance | ANNOUNCEMENT NO. 3175 October 2026 ChemoMetec maintained its positive momentum in the first quarter of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with... ► Artikel lesen | |
| POLAREAN IMAGING | 0,002 | 0,00 % | Polarean: Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 | ||
| PROMIMIC | 0,855 | -2,84 % | Promimic AB Q2 Sales Increase | ||
| DEVYSER DIAGNOSTICS | 4,520 | -0,88 % | Devyser Diagnostics AB: Devyser appoints Torben Thölix as the new Chief Commercial Officer | Devyser today announces the appointment of Torben Thölix as Chief Commercial Officer (CCO). Torben will lead Devyser's global commercial organization and join the executive management team, reporting... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab |
ARRAIL GROUP LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,203 (-100,00 %) liegt der Kurs bei 0,203 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ARRAIL GROUP LTD finden Sie auf Wallstreet Online.